Searcharxiv⌕ Search

arXiv · 2611.16099

CupOFMoCA: Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly

Abstract

Molecular conjugates, including PROTACs and peptide-drug conjugates (PDCs), derive their function from the joint behavior of multiple coupled components, yet most generative approaches design these components independently and combine them only after generation. Such staged pipelines ignore cross-component dependencies and often produce conjugates that are chemically invalid, fall outside empirical conjugate distributions, or lose function upon assembly. In this work, we introduce Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly (CupOFMoCA), a discrete generative method that enforces cross-component chemical constraints during conjugate generation. CupOFMoCA restricts guided updates to chemically feasible conjugate states and reweights local transitions using molecular design objectives. Across three PDC systems, coupled generation achieved 100% conjugation validity among valid peptides and increased valid yield over matched post-hoc filtering, with comparable predicted binding scores across the full valid sets. In three-seed evaluations of three PROTAC systems, CupOFMoCA achieved the highest assembly validity on two systems and generated more assembly-valid molecules per second than the evaluated baselines. We further evaluated the generated PROTACs with post-hoc DegradeMaster scoring and explicit-solvent molecular dynamics, supporting their predicted activity and conformational properties. Together, these results establish CupOFMoCA as an efficient generator of molecular conjugates, supporting therapeutic development via coordinated control of assembly and molecular properties.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ruoxi Rosie Zhang, Ziang Li, Jiatao Gu, Pranam Chatterjee. 2026-11-11. CupOFMoCA: Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly. https://searcharxiv.com/abs/2611.16099

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Searcharxiv by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related papers

Discovery of new antiviral agents through artificial intelligence: in vitro and in vivo results

In this research, we employed a deep reinforcement learning (RL)-based molecule design platform to generate a diverse set of compounds targeting the neuraminidase (NA) of influenza A and B viruses. A total of 60291 compounds were generated, of which 86.5% displayed superior physicochemical properties compared to oseltamivir. After narrowing down the selection through computational filters, nine compounds with non-sialic acid-like structures were selected for in vitro experiments. We identified two compounds, DS-22-inf-009 and DS-22-inf-021 that effectively inhibited the NAs of both influenza A and B viruses (IAV and IBV), including H275Y mutant strains at low micromolar concentrations. Molecular dynamics simulations revealed a similar pattern of interaction with amino acid residues as oseltamivir. In cell-based assays, DS-22-inf-009 and DS-22-inf-021 inhibited IAV and IBV in a dose-dependent manner with EC50 values ranging from 0.29 uM to 2.31 uM. Furthermore, animal experiments showed that both DS-22-inf-009 and DS-22-inf-021 exerted antiviral activity in mice, conferring 65% and 85% protection from IAV (H1N1 pdm09), and 65% and 100% protection from IBV (Yamagata lineage), respectively. Thus, these findings demonstrate the potential of RL to generate compounds with promising antiviral properties.

q-bio.BM↗

Agent-guided epitope excision enables economical de novo binder design

De novo protein design campaigns remain bottlenecked by the inference compute time required to generate and rank candidates, limiting wider functional exploration. Here, we introduce and evaluate an epitope excision approach that truncates targets to local interface windows to accelerate both backbone diffusion and structure prediction. Across 15 targets and 3,666 designs, excised windows closely reproduced full-target binding interfaces (median CαRMSD of 0.37 Å) and made it practical to design binders against the 719-residue extracellular domain of fibroblast activation protein alpha (FAP) by cutting RFdiffusion and AlphaFold3 GPU time by ~ 88% in one of the epitopes. Pairing this workflow with an agentic optimization loop allowed the system to autonomously identify catalytic-site targeting strategies. Under a fixed compute budget, a human-in-the-loop (HITL) workflow raised the computational hit rate from 5.06% to 9.33% while further cutting GPU hours by ~ 42%. We also found that omitting target multiple sequence alignments during refolding roughly substantially increased the apparent yield. Wet-lab validation with yeast display identified nanomolar binders from the generated designs with the HITL and the fully autonomous agent (human-out-of-the-loop, HOOTL) arms recovering more enriched designs than the PI-alone baseline. Together, target excision and agent-guided search offer a practical way to scale de novo binder design to large, therapeutically relevant proteins.

q-bio.BM↗

Cross-species digital xenocortication model delineates molecular correlates of human brain connectome

Cross-species digital xenocortication (CSDX) model based on pairing of a human brain structure with one or more mouse brain structures was constructed and implemented to dissect the molecular correlates of the human brain connectome. Design of the CSDX model is based on the assumption that a human brain region and its named mouse counterpart occupy corresponding positions in an evolutionary conserved mammalian brain connectome plan, so that a projection strength measured between two mouse structures is informative about the relation between the two human structures paired with them. In the CSDX model, gene expression for the node was measured in the human brain, while connection strength between two nodes was measured in the mouse brain. CSDX models of different parcellations were employed to explore the potential regulatory associations of brain connectome patterns and constituents of protein-protein interaction (PPI) cascades of hybrid assembly pathways of endogenous multiprotein complexes. Metrics of continuous engagement of the PPI cascade nucleated protein dimers of CORUM multiprotein complexes have been identified as statistical components of the multivariate transcriptome-connectome associations. It accounts for additional connectome associated variations beyond the five measured axes in the 82 nodes CSDX model. Comparisons of the seven arm models of transcriptome-connectome associations demonstrate that the mouse derived model generally fits the mouse brain connectome better, while the human derived model assigns a significantly larger fraction of its transcriptome-connectome association to unique rather than net shared contributions. This study nominates elite panels of top scoring candidate protein dimers and CORUM multiprotein complexes for follow up mechanistic studies of their potential roles in structural functional features governing mammalian brain connectome.

q-bio.BM↗